NATL HEALTH INVESTORS INC (NHI) 57.66 +0.74 (+1.3%)
57.66 +0.74 (+1.3%)
US63633D1046 - REIT - After market: 57.66 0 (0%)
Buy % Consensus
Analysts have set a mean price target of 62.05. This target is 7.61% above the current price.
NHI was analyzed by 10 analysts. The buy percentage consensus is at 70. So analysts seem to be have mildly positive about NHI.
In the last month the buy percentage rose by 19 points. So the trust of analysts is improving.
NHI was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-12-09 | Credit Suisse | Upgrade | Underperform -> Neutral |
| 2022-09-26 | Truist Securities | Maintains | Hold |
| 2022-06-21 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2022-04-19 | BMO Capital | Maintains | Outperform |
| 2022-02-01 | Credit Suisse | Initiate | Underperform |
| 2022-01-07 | BMO Capital | Upgrade | Market Perform -> Outperform |
| 2021-07-23 | Wells Fargo | Maintains | Equal-Weight |
| 2021-06-18 | BMO Capital | Upgrade | Underperform -> Market Perform |
| 2021-03-30 | Capital One Financial | Downgrade | Overweight -> Equal-Weight |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA